Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2003
03/12/2003WO2002024654A1 Amino heterocyclic compounds (factor xa inhibitors 14)
03/12/2003EP1291430A1 Ceramide kinase and dna encoding the same
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1290447A2 Peptide potentiation of acid-sensory ion channel in pain
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290188A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290174A2 G-protein coupled receptor org3.
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290152A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1290021A2 Polynucleotide sequence encoding a putative cell adhesion molecule
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289941A1 Carbamic acid esters as inhibitors of factor xa
03/12/2003EP1289939A1 Phenylglycine derivatives
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289558A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
03/12/2003EP1289541A2 Interferon for the treatment of multiple sclerosis
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289524A2 Porous celecoxib matrices and methods of manufacture thereof
03/12/2003EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives
03/12/2003EP1289516A1 Composition for pain mediation and apparatus and method of use thereof
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289501A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289499A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289498A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289497A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289475A2 Water-thin emulsions with low emulsifier levels
03/12/2003EP1135121B1 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
03/12/2003EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors
03/12/2003EP1083891B1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0869783B1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it
03/12/2003EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
03/12/2003EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402786A Production of complex carbohydrates
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1402734A 3-methylene steroid deriv.
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402730A Thiazolo (4,5-D) pyrimidine compounds
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same
03/12/2003CN1402709A 4-pyridinyl-N-acyl-L-phenylalanines
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401638A Pyrazoles derivs., Pharmaceutical salt thereof and composition contg. same
03/12/2003CN1401372A Antiinflammatory hemostatic gynecologic medicine and use thereof
03/12/2003CN1401355A 'Yuanzhengbitong' liquid for numbness
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1102931C Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action
03/12/2003CN1102852C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs
03/12/2003CA2422067A1 Aminoheterocycles (factor xa inhibitors 14)
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531473 Method of treatment using arylalkylpyridazinones
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531140 Anti-irritant compositions containing a cyclic nucleotide
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003CA2264254C Phosphinic acid amides as matrix metalloprotease inhibitors
03/11/2003CA2038416C Ascorbic acid derivatives
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors